Appendix contributors PedNet Study group members and centers
MT Alvarèz Román, Unidad de Coagulopatías, Hopital Universitario La Paz, Madrid, Spain; O Benítez-Hidalgo, Unitat Hemofilia, Hospital Vall d’Hebron, Barcelona, Spain; HM van den Berg, PedNet Haemophilia Research Foundation, Baarn, The Netherlands; M Carcao, Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada;
M Carvalho, Serviço de Imunoterapia, Centro de Referência de Coagulopatias Congénitas, Centro Hospitalar e Universitário São João, E.P.E., Porto, Portugal; E Chalmers, Department of Haematology, Royal Hospital for Sick Children, Yorkhill, Glasgow, UK; H Chambost, APHM, La Timone Children’s Hospital, Center for Bleeding Disorders & Aix Marseille Univ, INSERM, INRA, C2VN, Marseille, France; A Rosa Cid, Unidad de Hemostasia y Trombosis, Hospital Universitario y Politécnico La Fe, Valencia, Spain; S Claeyssens, Centre Regional d’Hemophilie, Centre Hospitalo Universitaire, Toulouse, France; C Escuriola, HZRM Hämophilie Zentrum Rhein Main GmbH, Mörfelden-Walldorf, Germany; C Van Geet, Catholic University of Leuven, Campus Gasthuisberg, Service of Pediatric Haematology, Leuven, Belgium; C Königs, University Hospital Frankfurt, Department of Paediatrics and Adolescent Medicine, Frankfurt, Germany; K Kurnik, Dr. V. Hauner Children’s Hospital, University of Munich, Munich, Germany; R Liesner, Hemophilia Center, Department of Haematology, Great Ormond Street Hospital for Children, London, UK; G Kenet, National Hemophilia Center Sheba Medical center, Tel Hashomer & Amalia Biron Research Institute of Thrombosis & Hemostasis, Tel Aviv University, Israel; C Male, Department of Paediatrics, Medical University Hospital of Vienna, Vienna, Austria; A Molinari, Dipartimento di Ematologia ed Oncologia, Unità Trombosi ed Emostasi, Ospedale Pediatrico Giannina Gaslini, Genova, Italy; J Motwani, Department of Haematology, The Children’s Hospital, Birmingham, UK; B Nolan, Department of Paediatric Haematology, Our Lady’s Children’s Hospital for Sick Children, Crumlin, Dublin, Ireland; R d’Oiron, Centre de Référence pour le Traitement des Maladies Hémorragiques (CRTH), Hôpital Bicêtre, Kremlin Bicêtre AP-HP , France; J Oldenburg, Institut für Experimentelle Hämatologie und Transfusionsmedizin, Universitätsklinikum Bonn, Germany; H Pergantou, Haemophilia-Haemostasis Unit, St. Sophia Children’s Hospital, Athens, Greece; S Ranta, Department of Pediatrics, Clinic of Coagulation Disorders, Karolinska Hospital, Stockholm, Sweden; G Rivard, Division of Hematology/Oncology, Hôpital St Justine, Montréal, Canada
References:
Andersson, N.G., Auerswald, G., Barnes, C., Carcao, M., Dunn, A.L., Fijnvandraat, K., Hoffmann, M., Kavakli, K., Kenet, G., Kobelt, R., Kurnik, K., Liesner, R., Makipernaa, A., Manco-Johnson, M.J., Mancuso, M.E., Molinari, A.C., Nolan, B., Perez Garrido, R., Petrini, P., Platokouki, H.E., Shapiro, A.D., Wu, R. & Ljung, R. (2017) Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment. Br J Haematol .
Blanchette, V.S., Key, N.S., Ljung, L.R., Manco-Johnson, M.J., van den Berg, H.M. & Srivastava, A. (2014) Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost,12, 1935-1939.
den Dunnen, J.T. (2017) Describing Sequence Variants Using HGVS Nomenclature. Methods Mol Biol, 1492, 243-251.
Eckhardt, C.L., van Velzen, A.S., Peters, M., Astermark, J., Brons, P.P., Castaman, G., Cnossen, M.H., Dors, N., Escuriola-Ettingshausen, C., Hamulyak, K., Hart, D.P., Hay, C.R., Haya, S., van Heerde, W.L., Hermans, C., Holmstrom, M., Jimenez-Yuste, V., Keenan, R.D., Klamroth, R., Laros-van Gorkom, B.A., Leebeek, F.W., Liesner, R., Makipernaa, A., Male, C., Mauser-Bunschoten, E., Mazzucconi, M.G., McRae, S., Meijer, K., Mitchell, M., Morfini, M., Nijziel, M., Oldenburg, J., Peerlinck, K., Petrini, P., Platokouki, H., Reitter-Pfoertner, S.E., Santagostino, E., Schinco, P., Smiers, F.J., Siegmund, B., Tagliaferri, A., Yee, T.T., Kamphuisen, P.W., van der Bom, J.G. & Fijnvandraat, K. (2013) Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. Blood, 122, 1954-1962.
Fischer, K., Ljung, R., Platokouki, H., Liesner, R., Claeyssens, S., Smink, E. & van den Berg, H.M. (2014) Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry. Haemophilia, 20, e280-286.
Gomez, K. & Chitlur, M. (2013) Survey of laboratory tests used in the diagnosis and evaluation of haemophilia A. Thromb Haemost,109, 738-743.
Gomez, K., Laffan, M., Keeney, S., Sutherland, M., Curry, N. & Lunt, P. (2019) Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors’ Organisation Good Practice Paper. Haemophilia, 25, 116-126.
Goodeve, A.C. & Peake, I.R. (2003) The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development. Semin Thromb Hemost, 29, 23-30.
Gouw, S.C., van den Berg, H.M., Oldenburg, J., Astermark, J., de Groot, P.G., Margaglione, M., Thompson, A.R., van Heerde, W., Boekhorst, J., Miller, C.H., le Cessie, S. & van der Bom, J.G. (2012) F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Blood, 119,2922-2934.
Gouw, S.C., van der Bom, J.G., Ljung, R., Escuriola, C., Cid, A.R., Claeyssens-Donadel, S., van Geet, C., Kenet, G., Makipernaa, A., Molinari, A.C., Muntean, W., Kobelt, R., Rivard, G., Santagostino, E., Thomas, A. & van den Berg, H.M. (2013) Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med,368, 231-239.
Johnsen, J.M., Fletcher, S.N., Huston, H., Roberge, S., Martin, B.K., Kircher, M., Josephson, N.C., Shendure, J., Ruuska, S., Koerper, M.A., Morales, J., Pierce, G.F., Aschman, D.J. & Konkle, B.A. (2017) Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Adv,1, 824-834.
Li, T., Miller, C.H., Payne, A.B. & Craig Hooper, W. (2013) The CDC Hemophilia B mutation project mutation list: a new online resource.Mol Genet Genomic Med, 1, 238-245.
Ljung, R., Kling, S., Sjorin, E. & Nilsson, I.M. (1991) More than half the sporadic cases of hemophilia A in Sweden are due to a recent mutation. Acta Paediatr Scand, 80, 343-348.
Mahlangu, J., Cerquiera, M. & Srivastava, A. (2018) Emerging therapies for haemophilia - Global perspective. Haemophilia, 24 Suppl 6, 15-21.
Manco-Johnson, M.J., Abshire, T.C., Shapiro, A.D., Riske, B., Hacker, M.R., Kilcoyne, R., Ingram, J.D., Manco-Johnson, M.L., Funk, S., Jacobson, L., Valentino, L.A., Hoots, W.K., Buchanan, G.R., DiMichele, D., Recht, M., Brown, D., Leissinger, C., Bleak, S., Cohen, A., Mathew, P., Matsunaga, A., Medeiros, D., Nugent, D., Thomas, G.A., Thompson, A.A., McRedmond, K., Soucie, J.M., Austin, H. & Evatt, B.L. (2007) Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia. New England Journal of Medicine,357, 535-544.
Mannucci, P.M. & Tuddenham, E.G. (2001) The hemophilias–from royal genes to gene therapy. N Engl J Med, 344, 1773-1779.
Martensson, A., Ivarsson, S., Letelier, A., Manderstedt, E., Hallden, C. & Ljung, R. (2016) Origin of mutation in sporadic cases of severe haemophilia A in Sweden. Clin Genet, 90, 63-68.
McVey, J.H., Rallapalli, P.M., Kemball-Cook, G., Hampshire, D.J., Giansily-Blaizot, M., Gomez, K., Perkins, S.J. & Ludlam, C.A. (2020) The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: Important resources for haemostasis clinicians and researchers. Haemophilia .
Niroula, A. & Vihinen, M. (2016) Variation Interpretation Predictors: Principles, Types, Performance, and Choice. Hum Mutat,37, 579-597.
Payne, A.B., Miller, C.H., Kelly, F.M., Michael Soucie, J. & Craig Hooper, W. (2013) The CDC Hemophilia A Mutation Project (CHAMP) mutation list: a new online resource. Hum Mutat, 34, E2382-2391.
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W.W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K. & Rehm, H.L. (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 17, 405-424.
Seary, M.E., Feldman, D. & Carcao, M.D. (2012) DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.Haemophilia, 18, 50-55.
Swystun, L.L. & James, P.D. (2017) Genetic diagnosis in hemophilia and von Willebrand disease. Blood Rev, 31, 47-56.